Search research articles
Contact Us
Filters
Showing results (161-170 of 294) with videos related to
Page
of 30
Sort By:
The British Journal of Surgery
|
October 1, 1980
The human tumour xenograft--a valid model in experimental chemotherapy?
A J Shorthouse, J F Smyth, G G Steel, et al.
Anti-Cancer Drugs
|
August 1, 1992
A phase II study of sulofenur (LY186641) in gastric cancer
A Kamthan, J H Scarffe, J Walling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity
Richard L Hayward, Janet S Macpherson, Jeff Cummings, et al.
Irish Medical Journal
|
March 9, 2012
A critical evaluation of HIPE data
A O'Callaghan, M P Colgan, C McGuigan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC
J F Smyth, I E Smith, C Sessa, et al.
Urological Research
|
January 1, 1992
Expression of interferon-gamma receptors on bladder cancer cells: does it correlate with biological response?
S J Hawkyard, A M Jackson, R A Hawkins, et al.
Gynecologic Oncology
|
July 13, 2007
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer
Graeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Physical Review Letters
|
April 7, 2010
Soliton steering by longitudinal modulation of the nonlinearity in waveguide arrays
Gaetano Assanto, Luis A Cisneros, Antonmaria A Minzoni, et al.
Oncology
|
March 1, 1996
Pentostatin (2'-deoxycoformycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: phase II study of the EORTC Early Clinical Trials Group
S Monfardini, R Sorio, F Cavalli, et al.
Cancer Research
|
March 31, 2001
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer
L M Gilmour, K G Macleod, A McCaig, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 294) with videos related to
Sort By:
Page
of 30
The British Journal of Surgery
|
October 1, 1980
The human tumour xenograft--a valid model in experimental chemotherapy?
A J Shorthouse, J F Smyth, G G Steel, et al.
Anti-Cancer Drugs
|
August 1, 1992
A phase II study of sulofenur (LY186641) in gastric cancer
A Kamthan, J H Scarffe, J Walling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity
Richard L Hayward, Janet S Macpherson, Jeff Cummings, et al.
Irish Medical Journal
|
March 9, 2012
A critical evaluation of HIPE data
A O'Callaghan, M P Colgan, C McGuigan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC
J F Smyth, I E Smith, C Sessa, et al.
Urological Research
|
January 1, 1992
Expression of interferon-gamma receptors on bladder cancer cells: does it correlate with biological response?
S J Hawkyard, A M Jackson, R A Hawkins, et al.
Gynecologic Oncology
|
July 13, 2007
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer
Graeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Physical Review Letters
|
April 7, 2010
Soliton steering by longitudinal modulation of the nonlinearity in waveguide arrays
Gaetano Assanto, Luis A Cisneros, Antonmaria A Minzoni, et al.
Oncology
|
March 1, 1996
Pentostatin (2'-deoxycoformycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: phase II study of the EORTC Early Clinical Trials Group
S Monfardini, R Sorio, F Cavalli, et al.
Cancer Research
|
March 31, 2001
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer
L M Gilmour, K G Macleod, A McCaig, et al.
Page
of 30